[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623578":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":49,"collaborators":18,"id":51,"slug":18,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":18,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":77,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Baylor Research Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"App Intervention","EXPERIMENTAL","Patients on the app intervention arm will receive educational messages via their healthcare portal smartphone app.",[13],"Other: Educational Information via Smartphone App",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Support","NO_INTERVENTION","Patients on the standard support arm who receive a positive blood test result and either do not access their healthcare portal smartphone app and\u002For do not schedule a colonoscopy within 2 weeks of the blood test result will receive the standard patient navigation support offered which typically includes explanation and education regarding their positive test result and referral to a gastroenterologist or other proceduralist for a colonoscopy.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Educational Information via Smartphone App","The educational messages will include information about the meaning of a positive test result, the patient's chances of having a CRC detected on colonoscopy, and the importance of early CRC detection.",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Page E Blas, MA","CONTACT","214-820-5424","page.blas@bswhealth.org",[31],{"facility":32,"status":18,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Baylor University Medical Center, Baylor Charles A Sammons Cancer Center","Dallas","Texas","75246","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-96.80667,32.78306,{"lat":42,"lon":41},[45,46],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},{"name":47,"role":48,"phone":18,"phoneExt":18,"email":18},"Ronan Kelly, MD MBA FASCO","PRINCIPAL_INVESTIGATOR",{"type":50,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100623578",false,"NCT07398456","Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas","SHIELD-TX","Inclusion Criteria:\n\n* patients aged 45-84 years of age\n* Considered by health-care providers to be \"average risk\" for CRC as determined by USPSTF guidelines\n* If a patient opts for BBST, they are able and willing to provide blood samples per protocol\n* Ability to understand and the willingness to participate in the study\n* Must have been seen in HTPN clinic within the past 24 months from study activation\n* Must have active MyBSW app portal account and\u002For establish account during study recruitment\n\nExclusion Criteria:\n\n* Patients with a personal history of CRC\n* Patients with a known high-risk family history of CRC precluding the patient from being average risk\n* Patients with known diagnosis of inflammatory bowel disease or history of polyps\n* Patients who are currently symptomatic for CRC such as: blood in the stool\n* Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study\n* Have a recorded up to date CRC screening in the EMR (within 1 year for FIT, 3 years for mt-sDNA, 10 years for colonoscopy)\n* Patients with a previous abnormal colonoscopy finding who are due for surveillance.",true,"ALL","45 Years","84 Years",{"count":62,"type":63},5500,"ESTIMATED","INTERVENTIONAL",[66],"NA","The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval.\n\nAdditional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.",[69],"Colorectal Cancer (CRC) Screening",[71,72,73,74,75,76],"blood-based screening test","cancer risk","colorectal cancer risk","circulating tumor DNA","cell-free DNA","colorectal cancer screening","NOT_YET_RECRUITING","2026-02-10",{"date":80,"type":81},"2026-02-12","ACTUAL",{"date":83,"type":63},"2026-06",{"date":85,"type":63},"2028-06",{"name":5,"class":6},1]